These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 404961)

  • 21. Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B.
    Duncan IB
    Antimicrob Agents Chemother; 1974 Jan; 5(1):9-15. PubMed ID: 4365116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
    Ismaeel NA
    Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
    Washington JA; Snyder RJ; Kohner PC; Wiltse CG; Ilstrup DM; McCall JT
    J Infect Dis; 1978 Feb; 137(2):103-11. PubMed ID: 415096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ionized calcium and soluble magnesium on the predictability of the performance of Mueller-Hinton agar susceptibility testing of Pseudomonas aeruginosa with gentamicin.
    Casillas E; Kenny MA; Minshew BH; Schoenknecht FD
    Antimicrob Agents Chemother; 1981 Jun; 19(6):987-92. PubMed ID: 6791589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of antimicrobial susceptibilities of Pseudomonas aeruginosa isolates, with and without plaques, from two hospitals.
    Flournoy DJ; Belobraydic KA; Qadri SM
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):391-2. PubMed ID: 3090386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergy between carbenicillin and an aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum.
    Reyes MP; El-Khatib MR; Brown WJ; Smith F; Lerner AM
    J Infect Dis; 1979 Aug; 140(2):192-202. PubMed ID: 113468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.
    Barry AL; Miller GH; Thornsberry C; Hare RS; Jones RN; Lorber RR; Ferraresi R; Cramer C
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1514-8. PubMed ID: 3124731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of ceftriaxone alone and in combination with gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
    Watanakunakorn C
    Antimicrob Agents Chemother; 1983 Aug; 24(2):305-6. PubMed ID: 6314890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Susceptibility of Pseudomonas aeruginosa recently isolated from clinical specimens to various antimicrobial agents and changes of susceptibility to carbenicillin, gentamicin and amikacin (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1980 Jun; 33(6):668-74. PubMed ID: 6779031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mezlocillin: a new acyl ureidopenicillin. Antimicrobial activity and combination effects with four aminoglycoside antibiotics.
    Schassan HH; Koperski K; Scherf H
    Chemotherapy; 1978; 24(3):134-42. PubMed ID: 95925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of the micro-media system, sceptor, and MIC-2000 microdilution methods for testing Pseudomonas aeruginosa against gentamicin, tobramycin, and amikacin.
    Woolfrey BF; Lally RT; Quall CO
    J Clin Microbiol; 1983 Feb; 17(2):312-6. PubMed ID: 6403574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of a commercial microdilution minimal inhibitory concentration procedure for aminoglycoside susceptibility testing of Pseudomonas aeruginosa.
    Etowski DC; Beckwith DG
    Am J Clin Pathol; 1981 Jun; 75(6):830-3. PubMed ID: 6789668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1977 May; 11(5):791-6. PubMed ID: 879733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of amikacin, gentamicin and tobramycin combined with carbenicillin or ticarcillin against Pseudomonas aeruginosa in vitro.
    Meitert E; Petrescu AM; Chiru M
    Arch Roum Pathol Exp Microbiol; 1985; 44(2):127-36. PubMed ID: 3938268
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics.
    Kelly MT; Matsen JM
    Antimicrob Agents Chemother; 1976 Mar; 9(3):440-7. PubMed ID: 1259402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli: correlation between MICs of clinical isolates and quality control organisms.
    Larson TA; Peterson LR; Gerding DN
    J Clin Microbiol; 1985 Nov; 22(5):819-21. PubMed ID: 3932459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Error rates associated with the use of recently proposed breakpoints for testing Pseudomonas aeruginosa versus gentamicin, tobramycin, and amikacin by the standardized disk agar diffusion test.
    Woolfrey BF; Fox JM; Quall CO; Lally RT
    Antimicrob Agents Chemother; 1983 Nov; 24(5):764-70. PubMed ID: 6419674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-hour minimal inhibitory concentration test of four antimicrobial agents for Pseudomonas aeruginosa.
    Brown WJ; Sautter RL
    Antimicrob Agents Chemother; 1977 Jun; 11(6):1064-6. PubMed ID: 406835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of minimum inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa.
    Woolfrey BF; Fox JM; Quall CO
    Am J Clin Pathol; 1981 Jan; 75(1):39-44. PubMed ID: 6779623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.